187 related articles for article (PubMed ID: 16149601)
1. [CA50].
Kawabe T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():645-6. PubMed ID: 16149601
[No Abstract] [Full Text] [Related]
2. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
3. [CA19-9].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
[No Abstract] [Full Text] [Related]
4. [CA546, CA602].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():647-50. PubMed ID: 16149602
[No Abstract] [Full Text] [Related]
5. [Squamous cell carcinoma antigen].
Nawata S; Sugino N; Kato H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
[No Abstract] [Full Text] [Related]
6. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
Anticancer Res; 1999; 19(4A):2477-80. PubMed ID: 10470177
[TBL] [Abstract][Full Text] [Related]
7. [NCC-ST-439].
Sugano K
Nihon Rinsho; 2005 Aug; 63 Suppl 8():681-3. PubMed ID: 16149610
[No Abstract] [Full Text] [Related]
8. [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
[TBL] [Abstract][Full Text] [Related]
9. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers for detecting pancreatic cancer].
Nakaizumi A; Tanaka S
Nihon Rinsho; 2006 Jan; 64 Suppl 1():144-7. PubMed ID: 16457238
[No Abstract] [Full Text] [Related]
11. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
12. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
13. [CA72-4 (TAG-72)].
Maida Y; Kyo S; Inoue M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
[No Abstract] [Full Text] [Related]
14. [CYFRA21-1].
Kitamura S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():654-8. PubMed ID: 16149604
[No Abstract] [Full Text] [Related]
15. [KMO1].
Kamigaki T; Kuroda Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():691-3. PubMed ID: 16149613
[No Abstract] [Full Text] [Related]
16. [DU-PAN-2, SPan-1].
Motoo Y; Sawabu N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():687-90. PubMed ID: 16149612
[No Abstract] [Full Text] [Related]
17. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
van Dalen A; Kessler AC
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
19. [Lewis antigens and CA19-9].
Naka K; Shimojo N
Nihon Rinsho; 1998 Jan; 56 Suppl 3():117-20. PubMed ID: 9513400
[No Abstract] [Full Text] [Related]
20. [CA125].
Kuzuya K; Kuwabara M; Ariyoshi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():637-41. PubMed ID: 16149599
[No Abstract] [Full Text] [Related]
[Next] [New Search]